683 Capital Management, LLC → Onconova Therapeutics, Inc. TRAW

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

5 transactions

5 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 3.82

699,850 shares short · -28.6% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-09	STOVER JACK E	director	Award	14,150	$0.68	$10K
2026-07-09	CAUTREELS WERNER	director	Award	14,150	$0.68	$10K
2026-04-16	ORBIMED ADVISORS LLC	10%+ owner	Buy	597,729	$1.67	$998K
2026-04-16	ORBIMED ADVISORS LLC	10%+ owner	Buy	597,729	$1.67	$1.00M
2026-04-16	ORBIMED ADVISORS LLC	10%+ owner	Buy	1,793,187	$1.67	$3.00M

Other 13D/G Filings on Onconova Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-01-29	SCHEDULE	ORBIMED ADVISORS LLC	19.90%	760,824	view →
2020-02-19	SC	683 Capital Management, LLC	—	—	view →
2018-02-26	SC	Reddy E Premkumar	—	—	view →
2018-02-16	SC	683 Capital Management, LLC	—	—	view →
2018-01-09	SC	SABBY MANAGEMENT, LLC	—	—	view →

Other Filings by 683 Capital Management, LLC

Filed	Form	Issuer	Stake	Shares
2026-06-11	SCHEDULE 13G	Gossamer Bio, Inc. GOSS	—	—	view →
2020-02-19	SC	Onconova Therapeutics, Inc. TRAW	—	—	view →
2018-02-16	SC	Onconova Therapeutics, Inc. TRAW	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →